NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working.
|
|
Join the NPC evidence-based therapeutics team as they discuss some important recent studies and therapeutic news. This month:
• LABAs may improve survival better than tiotropium in older patients with COPD
• Increased risk of mortality associated with tiotropium Respimat in COPD
• Even short-term treatment with NSAIDs can increase cardiovascular risk in patients with prior MI
Please click on the hyperlinks above to access the Rapid Reviews of these topics
The podcast lasts 14 minutes 52 seconds.
[display_podcast]
 |
Subscribe to the NPC podcast via the iTunes store |
 |
Subscribe to the NPC podcast via RSS feed |